Serplulimab Injection
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors (NCT06716619) | Guangzhou FineImmune Biotechnology Co., LTD. | 2025-02-13 |
Track Serplulimab Injection automatically
Every clearance here is in the API, with alerts when new ones post.